載入中
NASDAQHealthcareMedical - Devices
最新資料
US$8.98
−US$0.04 · -0.44%
Senseonics Holdings, Inc. operates as a medical technology enterprise, specializing in the development and commercialization of continuous glucose monitoring (CGM) systems. These innovative solutions cater to individuals with diabetes across the United States, Europe, the Middle East, and Africa. The company's core product offerings, Eversense and Eversense XL, are advanced implantable CGM devices. They function by continuously tracking glucose levels through an under-the-skin sensor, a detachable and rechargeable smart transmitter, and an intuitive mobile application. This setup enables real-time diabetes monitoring and management for durations of up to half a year. Senseonics delivers its products and services to healthcare providers and patients alike via an extensive network of distributors and strategic fulfillment partners. Additionally, the firm maintains a collaborative agreement with the University Hospitals Accountable Care Organization. Founded in 1996, Senseonics Holdings, Inc. is headquartered in Germantown, Maryland.
前收盤價
US$8.98
−US$0.04 · -0.44%
盤中時間採用ET。市場資料可能有所延遲。
Senseonics Holdings, Inc. operates as a medical technology enterprise, specializing in the development and commercialization of continuous glucose monitoring (CGM) systems. These innovative solutions cater to individuals with diabetes across the United States, Europe, the Middle East, and Africa. The company's core product offerings, Eversense and Eversense XL, are advanced implantable CGM devices. They function by continuously tracking glucose levels through an under-the-skin sensor, a detachable and rechargeable smart transmitter, and an intuitive mobile application. This setup enables real-time diabetes monitoring and management for durations of up to half a year. Senseonics delivers its products and services to healthcare providers and patients alike via an extensive network of distributors and strategic fulfillment partners. Additionally, the firm maintains a collaborative agreement with the University Hospitals Accountable Care Organization. Founded in 1996, Senseonics Holdings, Inc. is headquartered in Germantown, Maryland.
日內區間
目前US$8.98
52週區間
目前US$8.98
盤中時間採用ET。市場資料可能有所延遲。
Senseonics Holdings, Inc. operates as a medical technology enterprise, specializing in the development and commercialization of continuous glucose monitoring (CGM) systems. These innovative solutions cater to individuals with diabetes across the United States, Europe, the Middle East, and Africa. The company's core product offerings, Eversense and Eversense XL, are advanced implantable CGM devices. They function by continuously tracking glucose levels through an under-the-skin sensor, a detachable and rechargeable smart transmitter, and an intuitive mobile application. This setup enables real-time diabetes monitoring and management for durations of up to half a year. Senseonics delivers its products and services to healthcare providers and patients alike via an extensive network of distributors and strategic fulfillment partners. Additionally, the firm maintains a collaborative agreement with the University Hospitals Accountable Care Organization. Founded in 1996, Senseonics Holdings, Inc. is headquartered in Germantown, Maryland.
日內區間
目前US$8.98
52週區間
目前US$8.98
獲利能力占已公布營收的百分比。
營收
營業利益
淨利
| 項目（USD） | 2025會計年度 | 2024會計年度 | 2023會計年度 | 2022會計年度 | 2021會計年度 |
|---|---|---|---|---|---|
| 營收 | 3525.7萬 USD | 2247.2萬 USD | 2239萬 USD | 1638.9萬 USD | 1367.5萬 USD |
| 銷貨成本 | 1949.4萬 USD | 2193.9萬 USD | 1929.9萬 USD | 1366.3萬 USD | 1448.6萬 USD |
| 毛利 | 1576.3萬 USD | 53.3萬 USD | 309.1萬 USD | 272.6萬 USD | −81.1萬 USD |
| 研究與開發 | 3159.2萬 USD | 4114.4萬 USD | 4875.2萬 USD | 3971.9萬 USD | 2721.7萬 USD |
| 銷售、一般及管理費用 | 5250.8萬 USD | 3423.1萬 USD | 2994.2萬 USD | 3163.4萬 USD | 2915.4萬 USD |
| 營業費用 | 8410萬 USD | 7537.5萬 USD | 7869.4萬 USD | 7135.3萬 USD | 5637.1萬 USD |
| 利息收入 | 419.8萬 USD | 450.2萬 USD | 536.2萬 USD | 182.4萬 USD | 24.3萬 USD |
| 利息支出 | 495.1萬 USD | 843.7萬 USD | 1111萬 USD | 1870.3萬 USD | 1672萬 USD |
| 折舊和攤銷 | 151.2萬 USD | 147.5萬 USD | 127.7萬 USD | 98.5萬 USD | 123.9萬 USD |
| 營業利益 | −6833.7萬 USD | −7484.2萬 USD | −7560.3萬 USD | −6862.7萬 USD | −5718.2萬 USD |
| 淨利 | −6911.3萬 USD | −7861.6萬 USD | −6039.2萬 USD | 1.42億 USD | −3.02億 USD |
公司資料更新於 2026年10月11日。
近期已公布業績
近期已公布業績
第三方分析師預期可能變動，並非 GoAI 建議。
平均目標
US$13.00
上漲空間 44.77%報告持有此股票曝險的交易所交易基金。
Vanguard Morningstar Total Stock Market ETFVTI1084.7萬0.00%2.3兆 USD0.03%US$381.94+0.63%
iShares Russell 2000 ETFIWM893.34萬0.01%787.4億 USD0.19%US$278.94+0.49%
Vanguard Extended Market ETFVXF519.14萬0.01%954億 USD0.05%US$235+0.80%
iShares Russell 2000 Growth ETFIWO313.18萬0.02%139.17億 USD0.24%US$356.78+0.94%
Schwab U.S. Small-Cap ETFSCHA234.99萬0.01%218.24億 USD0.03%US$32.79+0.40%
Vanguard Russell 2000 ETFVTWO209.11萬0.01%180億 USD0.06%US$112.66+0.50%
Invesco Dorsey Wright SmallCap Momentum ETFDWAS144.14萬0.36%3.99億 USD0.60%US$107.24+1.40%
iShares Micro-Cap ETFIWC106.33萬0.08%13.17億 USD0.60%US$183+0.11%Vanguard Morningstar Total Stock Market ETFVTIiShares Russell 2000 ETFIWMVanguard Extended Market ETFVXFiShares Russell 2000 Growth ETFIWOSchwab U.S. Small-Cap ETFSCHAVanguard Russell 2000 ETFVTWOInvesco Dorsey Wright SmallCap Momentum ETFDWASiShares Micro-Cap ETFIWCAI 生成內容及延遲市場資料僅供資訊與教育用途，不構成投資建議。
